Andrew T. Jay

ANDREW T. JAY follows medical technology at First Union Securities. He
has been a sell-side analyst on Wall Street for six years and is widely
known for his work with emerging growth companies such as Perclose,
Target Therapeutics and Wesley Jessen. His previous work experience
includes three years of management consulting with a major firm and five
years running a sizable dental practice. Dr. Jay holds an M.B.A. from
Northwestern’s Kellogg School and a D.M.D. from the University of
Pennsylvania. He completed his Bachelor of Science degree at Rensselaer
Polytechnic Institute in two years. Dr. Jay serves on the Board of
Directors at the Epilepsy Foundation of Massachusetts and Rhode Island.